{"id":908470,"date":"2026-06-22T03:33:43","date_gmt":"2026-06-22T03:33:43","guid":{"rendered":"http:\/\/cri-one-origin-the-origin-of-the-neurotransmitter-diagnostic-health-wellness-series-2017-invent-deposition-133"},"modified":"2026-06-22T03:33:43","modified_gmt":"2026-06-22T03:33:43","slug":"the-origin-of-the-neurotransmitter-diagnostic-health-wellness-series-2017-invent-deposition-133-3","status":"publish","type":"post","link":"https:\/\/cri-one.com\/blog\/2026\/06\/22\/the-origin-of-the-neurotransmitter-diagnostic-health-wellness-series-2017-invent-deposition-133-3\/","title":{"rendered":"The Origin of the Neurotransmitter Diagnostic \u2014 Health & Wellness Series \u2014 2017 Invent Deposition #133"},"content":{"rendered":"

FIRST TO MARKET<\/strong> \u00b7 Publicly documented 2017 \u00b7 Invent Deposition #133<\/p>\n

Among the 1,739 depositions in the 2017 Invent Depositions<\/em> corpus, #133<\/strong> is the closest match to Project 22 \u2014 Brain Chemistry<\/strong> and the neurodegenerative-disease discovery threads (Projects 11 \/ 12) on cri-one.com.<\/p>\n

\n

“mission 1: diagnose changes at dopamine, serotonin, adrenaline and histamine receptor sites in the central nervous system by using a similar method to diabetic blood testing.” \u2014 Christopher Gabriel Brown, 2017<\/p>\n<\/blockquote>\n

From one line to an engineered product<\/h2>\n

The 2017 abstract proposes a point-of-care assay for central-nervous-system neurotransmitter receptor activity, modeled on the familiar glucose-test workflow \u2014 making brain-chemistry status as routinely measurable as blood sugar. Project 22 (Brain Chemistry) and the Alzheimer’s\/Parkinson’s discovery projects build on this receptor-site measurement thesis.<\/p>\n

The idea graduated from a one-line deposition into a patent-pending research program without changing its founding claim: make neurotransmitter status as measurable as blood glucose.<\/strong><\/p>\n

\n

Note: this is research-stage IP. Nothing here is a medical device, a diagnostic claim, or medical advice.<\/p>\n<\/blockquote>\n

Provenance<\/h2>\n
    \n
  • Source: Invent Depositions<\/em> (2017), ISBN-13 978-1-979767-89-7, CreateSpace<\/li>\n
  • Catalog image: Firefly_133\u2026jpg<\/code> (buyinvent.com)<\/li>\n
  • Live products: Project 22 (Brain Chemistry) \u00b7 Projects 11 \/ 12 (cure-discovery threads)<\/li>\n<\/ul>\n

    Cite this<\/h2>\n
      \n
    • AP<\/strong> \u2014 Brown, C. G. (2017). Invent Depositions<\/em>, Deposition #133. CreateSpace.<\/li>\n
    • APA<\/strong> \u2014 Brown, C. G. (2017). Invent depositions<\/em> (Deposition No. 133). CreateSpace Independent Publishing Platform.<\/li>\n
    • MLA<\/strong> \u2014 Brown, Christopher Gabriel. Invent Depositions<\/em>, Deposition #133. CreateSpace, 2017.<\/li>\n<\/ul>\n
      \n

      \u00a9 2017 Christopher Gabriel Brown \u00b7 Patent Pending \u00b7 IP retained by CRI-ONE<\/p>\n","protected":false},"excerpt":{"rendered":"

      FIRST TO MARKET \u00b7 Publicly documented 2017 \u00b7 Invent Deposition #133 Among the 1,739 depositions in the 2017 Invent Depositions corpus, #133 is the closest match to Project 22 \u2014 Brain Chemistry and the neurodegenerative-disease discovery threads (Projects 11 \/ 12) on cri-one.com. “mission 1: diagnose changes at dopamine, serotonin, adrenaline and histamine receptor sites […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[627],"tags":[],"class_list":["post-908470","post","type-post","status-publish","format-standard","hentry","category-gallery"],"_links":{"self":[{"href":"https:\/\/cri-one.com\/blog\/wp-json\/wp\/v2\/posts\/908470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cri-one.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cri-one.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cri-one.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cri-one.com\/blog\/wp-json\/wp\/v2\/comments?post=908470"}],"version-history":[{"count":1,"href":"https:\/\/cri-one.com\/blog\/wp-json\/wp\/v2\/posts\/908470\/revisions"}],"predecessor-version":[{"id":911367,"href":"https:\/\/cri-one.com\/blog\/wp-json\/wp\/v2\/posts\/908470\/revisions\/911367"}],"wp:attachment":[{"href":"https:\/\/cri-one.com\/blog\/wp-json\/wp\/v2\/media?parent=908470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cri-one.com\/blog\/wp-json\/wp\/v2\/categories?post=908470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cri-one.com\/blog\/wp-json\/wp\/v2\/tags?post=908470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}